Merck Limited has informed the Exchange regarding 'We have been informed today, on November 27, 2018 that the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, by a letter dated November 26, 2018, has approved the proposal dated July 2, 2018 of Merck Specialties Private Limited inter alia for acquisition of the biopharmaceuticals business of the Company by Merck Specialties Private Limited by way of a slump sale. We are making this announcement pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. The Exchange disclaims any liability arising out of the contents of the information uploaded by the Company and in no event, Exchange will be held liable for any damages, claims arising out of such information.